ArticleInfectious diseases and therapy2025

Symptom Alleviation/Resolution and Returns to Usual Health/Activities in Immunocompromised Adults with COVID-19 Treated with Nirmatrelvir-Ritonavir: Results from the EPIC-IC Trial.

Ruth Mokgokong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.